CME Group Inc.
CME
$285.75
$3.171.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.77B | 1.54B | 1.43B | 1.59B | 1.53B |
| Total Other Revenue | 109.50M | 108.40M | 104.00M | 102.60M | 107.60M |
| Total Revenue | 1.88B | 1.64B | 1.53B | 1.69B | 1.64B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.88B | 1.64B | 1.53B | 1.69B | 1.64B |
| SG&A Expenses | 446.60M | 473.10M | 440.00M | 430.30M | 407.30M |
| Depreciation & Amortization | 83.30M | 82.40M | 82.60M | 83.40M | 82.50M |
| Other Operating Expenses | 36.60M | 39.60M | 39.20M | 45.70M | 41.60M |
| Total Operating Expenses | 566.50M | 595.10M | 561.80M | 559.40M | 531.40M |
| Operating Income | 1.31B | 1.05B | 972.60M | 1.13B | 1.11B |
| Income Before Tax | 1.51B | 1.58B | 1.18B | 1.33B | 1.24B |
| Income Tax Expenses | 356.60M | 395.50M | 269.00M | 305.20M | 288.60M |
| Earnings from Continuing Operations | 1.15B | 1.18B | 908.00M | 1.03B | 956.20M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.15B | 1.18B | 908.00M | 1.03B | 956.20M |
| EBIT | 1.31B | 1.05B | 972.60M | 1.13B | 1.11B |
| EBITDA | 1.39B | 1.13B | 1.06B | 1.21B | 1.19B |
| EPS Basic | 3.25 | 3.25 | 2.49 | 2.81 | 2.63 |
| Normalized Basic EPS | 2.63 | 2.71 | 2.05 | 2.31 | 2.16 |
| EPS Diluted | 3.18 | 3.24 | 2.49 | 2.81 | 2.62 |
| Normalized Diluted EPS | 2.60 | 2.71 | 2.04 | 2.31 | 2.16 |
| Average Basic Shares Outstanding | 359.32M | 359.63M | 359.69M | 359.66M | 359.61M |
| Average Diluted Shares Outstanding | 363.21M | 360.23M | 360.42M | 360.36M | 360.23M |
| Dividend Per Share | 1.30 | 1.25 | 1.25 | 1.25 | 1.25 |
| Payout Ratio | 233.70% | 38.46% | 50.14% | 44.42% | 268.50% |